Introduction: Who Should Undergo Diagnostics
If you have been diagnosed with cancer, your doctor will want to check whether the disease has spread to your lymph nodes, which are small oval-shaped organs scattered throughout your body. These nodes normally act as filters that trap infections and harmful cells, but cancer can hijack this system to travel to other parts of your body.[1] When cancer moves into lymph nodes, it’s called lymph node metastasis, and finding out early whether this has happened is crucial for planning your treatment.
You should undergo diagnostic testing for lymph node involvement if you’ve recently been diagnosed with cancer, especially certain types that commonly spread this way. Breast cancer, melanoma (a type of skin cancer), and cancers of the head and neck, lungs, pancreas, and digestive system are particularly likely to move into nearby lymph nodes.[2] The location of your original tumor and how deeply it has grown into surrounding tissue help doctors predict which lymph nodes might be affected.
Even if you don’t feel anything unusual, your doctor may recommend lymph node testing. Many people with cancer in their lymph nodes have no symptoms at all, especially when the affected nodes are located deep inside the body, such as in the chest or abdomen.[1] Sometimes the first sign is a lump in your neck, armpit, or groin that feels hard and doesn’t go away after a couple of weeks. Unlike swollen lymph nodes from an infection, which are usually tender and painful, cancerous nodes typically don’t hurt when you press on them.[7]
After cancer surgery, your surgeon will routinely remove some lymph nodes from the area near the tumor to check them for cancer cells. This is a standard part of cancer care because finding cancer in the lymphatic system tells doctors whether there’s a higher chance the disease could come back or spread further.[1] If you’ve completed cancer treatment in the past, your doctor will continue checking your lymph nodes during follow-up visits to watch for signs that the cancer has returned.
Diagnostic Methods for Identifying Lymph Node Metastases
When your doctor suspects that cancer may have spread to your lymph nodes, several different tests can help confirm or rule out this possibility. The choice of which test to use depends on where your lymph nodes are located, what type of cancer you have, and what equipment is available at your medical center.
Physical Examination
The diagnostic process often begins with a simple physical exam. Your doctor will carefully feel areas of your body where lymph nodes are close to the surface, such as your neck, armpits, and groin. They’re checking for nodes that have become enlarged, feel unusually hard, or seem fixed in place rather than moving slightly under the skin.[7] While this exam cannot detect deeply located nodes or very small areas of cancer spread, it’s a quick first step that helps guide further testing.
Imaging Tests
Several types of imaging allow doctors to see inside your body and identify enlarged or suspicious lymph nodes. Ultrasound uses sound waves to create pictures and works well for lymph nodes near the skin surface, like those in the armpit or neck. It’s painless and doesn’t use radiation, making it a good option for repeated checks over time.[7]
CT scans (computed tomography) take multiple X-ray images from different angles and combine them into detailed cross-sectional pictures of your body. These scans can reveal lymph nodes throughout your chest, abdomen, and pelvis that cannot be felt during a physical exam.[2] Your doctor may ask you to drink a contrast liquid or receive it through an IV to make certain tissues show up more clearly on the images.
MRI scans (magnetic resonance imaging) use powerful magnets and radio waves instead of radiation to create very detailed images of soft tissues. MRI is particularly useful for looking at lymph nodes in areas where fine detail matters, such as near the spine or brain.[2] The test takes longer than a CT scan and requires you to lie still inside a tube-shaped machine that can feel confining to some people.
PET scans (positron emission tomography) work differently from other imaging tests. You receive an injection of a small amount of radioactive sugar, which cancer cells absorb more eagerly than normal cells. A special camera then takes pictures showing where this radioactive material has collected, highlighting areas of active cancer throughout your body, including in lymph nodes.[2] PET scans are often combined with CT scans to provide both functional and structural information at the same time.
Biopsy Procedures
While imaging tests can show that lymph nodes look abnormal, a biopsy is usually needed to know for certain whether cancer is present. During a biopsy, doctors remove a small sample of tissue from a suspicious lymph node to examine under a microscope.[2] There are several ways to perform a lymph node biopsy.
A fine needle aspiration uses a thin needle to draw out cells from the lymph node. This quick procedure can often be done in a doctor’s office with only local numbing medicine. However, because it collects only a small number of cells, it might miss cancer that’s present or not provide enough tissue for all the tests your doctor wants to run.
A core needle biopsy uses a slightly larger needle to remove a small cylinder of tissue from the node. This provides more material for examination than fine needle aspiration while still being a relatively minor procedure. The doctor may use ultrasound or CT images to guide the needle to exactly the right spot.
An excisional biopsy means surgically removing an entire lymph node or group of nodes. This requires a small surgical incision and provides the most tissue for testing, allowing pathologists to examine the node’s structure in detail. For some patients, this happens during cancer surgery, when the surgeon removes nearby lymph nodes at the same time as the main tumor.[1]
A sentinel lymph node biopsy is a specialized technique used particularly in breast cancer and melanoma. The surgeon injects a blue dye or radioactive tracer near the tumor, which flows through the lymphatic vessels to the first lymph node that drains that area—called the sentinel node. By removing and testing only this “first stop” node, doctors can often determine whether cancer has spread without removing many nodes, which reduces the risk of side effects like swelling.[18]
Blood Tests and Tumor Markers
While blood tests cannot directly show whether cancer is in your lymph nodes, certain tumor marker tests measure substances that cancer cells release into the bloodstream. Rising levels of these markers might suggest that cancer is growing or spreading, prompting your doctor to look more closely at your lymph nodes and other areas.[2] However, tumor markers are not definitive on their own because other conditions can also cause them to rise.
Distinguishing Metastases from Other Conditions
Not every enlarged lymph node contains cancer. Infections, autoimmune diseases, and even reactions to vaccines can make lymph nodes swell temporarily. This is why doctors look at multiple factors together: the node’s size and texture, how long it has been enlarged, whether you have other symptoms like fever or pain, and what imaging tests reveal about its internal structure.[1]
When cancer cells are found in a lymph node, pathologists examine them carefully under the microscope. Interestingly, these cells will look like the original cancer, not like normal lymph node tissue. For example, if pancreatic cancer has spread to a neck lymph node, the cells in that node will still appear to be pancreatic cancer cells.[1] This helps confirm where the cancer started and guides treatment decisions.
Diagnostics for Clinical Trial Qualification
Clinical trials are research studies that test new treatments or combinations of treatments for cancer. If you’re considering joining a clinical trial, you’ll need to undergo specific diagnostic tests that help researchers determine whether you’re eligible and ensure the study results will be meaningful.
Most cancer clinical trials use a staging system to categorize patients based on how far their disease has spread. The presence and extent of lymph node metastases is a key part of this staging. The most common system, called TNM staging, evaluates three factors: the size and characteristics of the primary Tumor (T), whether cancer has spread to lymph Nodes (N), and whether there are distant Metastases (M).[7] Your lymph node status might be classified as N0 (no lymph node involvement), N1, N2, or N3, with higher numbers indicating more extensive spread.
To establish your N classification for trial entry, you’ll typically need imaging studies such as CT scans, MRI, or PET scans that clearly show whether lymph nodes contain cancer and, if so, how many nodes are affected and where they’re located.[2] Some trials require specific types of imaging—for instance, a PET-CT scan rather than a regular CT—so that all participants are evaluated consistently.
Many trials also require biopsy confirmation that cancer is present in the lymph nodes, rather than relying on imaging appearance alone. This ensures that only patients who truly have metastatic disease are included in studies testing treatments for advanced cancer.[2] If imaging shows suspicious lymph nodes but you haven’t had a biopsy yet, the trial might require one before you can enroll.
Beyond confirming the presence of lymph node metastases, some clinical trials need additional information about the cancer cells themselves. For studies testing targeted therapies or immunotherapies, researchers may need to know whether your cancer cells have specific genetic mutations or produce certain proteins. These specialized tests, sometimes called companion diagnostics, are performed on tissue from your biopsy.[6] The results determine whether the treatment being studied is likely to work for your particular type of cancer.
Clinical trials have strict eligibility criteria to ensure participant safety and produce reliable scientific results. Your diagnostic test results must show that your cancer fits the specific characteristics the study is designed to examine. For example, a trial might only accept patients whose cancer has spread to a certain number of lymph nodes but not yet to distant organs like the liver or lungs. Or it might specifically seek patients with lymph node metastases in a particular location, such as the armpit for breast cancer studies.
You’ll also need baseline diagnostic tests before starting any trial treatment. These might include blood tests checking your liver and kidney function, blood cell counts, and heart tests if the treatment might affect these organs. By documenting your condition before treatment begins, researchers can later determine whether the experimental therapy caused any changes—good or bad—and how effective it was at controlling the cancer in your lymph nodes.
Throughout the clinical trial, you’ll undergo regular diagnostic testing to monitor how your cancer responds to treatment. These follow-up scans and tests are scheduled at specific intervals according to the study protocol. The consistent timing allows researchers to compare results across all participants and measure accurately whether lymph node metastases are shrinking, staying stable, or growing despite treatment.




